Novartis’ ‘life-changing’ Ilaris set for NHS fundingPharmaTimesMon, March 2nd - 6:04 AM 2020
Largest ever eating disorders study launched in UKPharmaTimesMon, March 2nd - 6:08 AM 2020
EMA PRIME status granted to Janssen’s inherited retinal disease gene therapyPharmaTimesTue, March 3rd - 5:57 AM 2020
GW Pharma regains Sativex rights in UKPharmaTimesTue, March 3rd - 6:08 AM 2020
Gilead strikes $4.9bn deal to buy Forty SevenPharmaTimesTue, March 3rd - 6:27 AM 2020
Keytruda improves PFS in classical Hodgkin lymphomaPharmaTimesTue, March 3rd - 6:31 AM 2020
Xpovio hits endpoints in Phase III multiple myeloma trialPharmaTimesWed, March 4th - 4:29 AM 2020
FDA approves Sarclisa for relapsed refractory multiple myelomaPharmaTimesWed, March 4th - 4:37 AM 2020
First patient dosed in potential lymphoedema treatment trialPharmaTimesWed, March 4th - 4:45 AM 2020
App to determine risk of preterm birth developedPharmaTimesWed, March 4th - 4:52 AM 2020

Pages